Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer

To investigate the exposure–safety relationships of afatinib in Japanese population, we performed population pharmacokinetics (PK) analysis of afatinib in Japanese advanced non-small cell lung cancer patients harboring epidermal growth factor receptor mutation. Plasma samples were collected at 0.5–1...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Sci Rep
Asıl Yazarlar: Nakao, Keiko, Kobuchi, Shinji, Marutani, Shuhei, Iwazaki, Ayano, Tamiya, Akihiro, Isa, Shunichi, Okishio, Kyoichi, Kanazu, Masaki, Tamiya, Motohiro, Hirashima, Tomonori, Imai, Kimie, Sakaeda, Toshiyuki, Atagi, Shinji
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6890782/
https://ncbi.nlm.nih.gov/pubmed/31796841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-54804-9
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller